1. Home
  2. SANM vs BLCO Comparison

SANM vs BLCO Comparison

Compare SANM & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanmina Corporation

SANM

Sanmina Corporation

HOLD

Current Price

$176.78

Market Cap

6.2B

Sector

Technology

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.39

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SANM
BLCO
Founded
1980
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Electrical Products
Ophthalmic Goods
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.0B
IPO Year
1993
2022

Fundamental Metrics

Financial Performance
Metric
SANM
BLCO
Price
$176.78
$17.39
Analyst Decision
Hold
Hold
Analyst Count
1
14
Target Price
$120.00
$17.31
AVG Volume (30 Days)
625.8K
413.8K
Earning Date
01-26-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
14.07
N/A
EPS
4.46
N/A
Revenue
$8,128,382,000.00
$4,976,000,000.00
Revenue This Year
$75.74
$8.08
Revenue Next Year
$12.92
$5.77
P/E Ratio
$39.60
N/A
Revenue Growth
7.40
6.23
52 Week Low
$63.67
$10.45
52 Week High
$178.39
$20.71

Technical Indicators

Market Signals
Indicator
SANM
BLCO
Relative Strength Index (RSI) 68.85 66.31
Support Level $157.25 $16.39
Resistance Level $167.06 $17.35
Average True Range (ATR) 6.95 0.48
MACD 1.15 0.08
Stochastic Oscillator 99.42 88.63

Price Performance

Historical Comparison
SANM
BLCO

About SANM Sanmina Corporation

Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue primarily in the United States, China, and Mexico, but has a presence around the world.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: